Cytek Biosciences Statistics
Total Valuation
CTKB has a market cap or net worth of $482.93 million. The enterprise value is $222.08 million.
Important Dates
The next confirmed earnings date is Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CTKB has 128.10 million shares outstanding. The number of shares has decreased by -3.45% in one year.
| Current Share Class | 128.10M |
| Shares Outstanding | 128.10M |
| Shares Change (YoY) | -3.45% |
| Shares Change (QoQ) | -2.79% |
| Owned by Insiders (%) | 9.03% |
| Owned by Institutions (%) | 55.47% |
| Float | 109.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 34.27 |
| PS Ratio | 2.46 |
| Forward PS | 2.24 |
| PB Ratio | 1.23 |
| P/TBV Ratio | 1.35 |
| P/FCF Ratio | 22.10 |
| P/OCF Ratio | 19.03 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 10.16 |
Financial Position
The company has a current ratio of 5.86, with a Debt / Equity ratio of 0.04.
| Current Ratio | 5.86 |
| Quick Ratio | 5.00 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.78 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1.53% and return on invested capital (ROIC) is -3.53%.
| Return on Equity (ROE) | -1.53% |
| Return on Assets (ROA) | -2.91% |
| Return on Invested Capital (ROIC) | -3.53% |
| Return on Capital Employed (ROCE) | -5.35% |
| Revenue Per Employee | $309,341 |
| Profits Per Employee | -$9,290 |
| Employee Count | 648 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.70 |
Taxes
In the past 12 months, CTKB has paid $320,000 in taxes.
| Income Tax | 320,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.39% in the last 52 weeks. The beta is 1.41, so CTKB's price volatility has been higher than the market average.
| Beta (5Y) | 1.41 |
| 52-Week Price Change | -33.39% |
| 50-Day Moving Average | 4.24 |
| 200-Day Moving Average | 5.44 |
| Relative Strength Index (RSI) | 44.21 |
| Average Volume (20 Days) | 774,458 |
Short Selling Information
The latest short interest is 4.14 million, so 3.23% of the outstanding shares have been sold short.
| Short Interest | 4.14M |
| Short Previous Month | 4.53M |
| Short % of Shares Out | 3.23% |
| Short % of Float | 3.77% |
| Short Ratio (days to cover) | 4.26 |
Income Statement
In the last 12 months, CTKB had revenue of $200.45 million and -$6.02 million in losses. Loss per share was -$0.05.
| Revenue | 200.45M |
| Gross Profit | 111.11M |
| Operating Income | -23.12M |
| Pretax Income | -16.25M |
| Net Income | -6.02M |
| EBITDA | -15.91M |
| EBIT | -23.12M |
| Loss Per Share | -$0.05 |
Full Income StatementBalance Sheet
The company has $277.86 million in cash and $17.02 million in debt, giving a net cash position of $260.85 million or $2.04 per share.
| Cash & Cash Equivalents | 277.86M |
| Total Debt | 17.02M |
| Net Cash | 260.85M |
| Net Cash Per Share | $2.04 |
| Equity (Book Value) | 395.74M |
| Book Value Per Share | 3.06 |
| Working Capital | 328.78M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $25.38 million and capital expenditures -$3.53 million, giving a free cash flow of $21.85 million.
| Operating Cash Flow | 25.38M |
| Capital Expenditures | -3.53M |
| Free Cash Flow | 21.85M |
| FCF Per Share | $0.17 |
Full Cash Flow StatementMargins
Gross margin is 55.43%, with operating and profit margins of -11.54% and -3.00%.
| Gross Margin | 55.43% |
| Operating Margin | -11.54% |
| Pretax Margin | -2.84% |
| Profit Margin | -3.00% |
| EBITDA Margin | -7.94% |
| EBIT Margin | -11.54% |
| FCF Margin | 10.90% |
Dividends & Yields
CTKB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.45% |
| Shareholder Yield | n/a |
| Earnings Yield | -1.25% |
| FCF Yield | 4.53% |
Analyst Forecast
The average price target for CTKB is $7.00, which is 85.68% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.00 |
| Price Target Difference | 85.68% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTKB has an Altman Z-Score of 5.79 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.79 |
| Piotroski F-Score | 4 |